Pfizer's Lyme disease vaccine candidate shows promising results
#Pfizer #Lyme disease #vaccine #clinical trials #tick-borne illness #prevention #public health
📌 Key Takeaways
- Pfizer's Lyme disease vaccine candidate demonstrates positive efficacy in trials
- The vaccine aims to prevent Lyme disease transmitted by tick bites
- Results indicate potential for significant reduction in infection rates
- Further studies are needed before regulatory approval and public availability
📖 Full Retelling
Presented by Alliance for Aging Research {beacon} Health Care Health Care PRESENTED BY The Big Story Pfizer's Lyme disease vaccine candidate shows promising results Results from a phase 3 clinical trial of Pfizer's Lyme disease vaccine candidate found it was more than 70 percent effective at preventing the illness. © Associated Press Participants in...
🏷️ Themes
Medical Research, Vaccine Development
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
Presented by Alliance for Aging Research {beacon} Health Care Health Care PRESENTED BY The Big Story Pfizer's Lyme disease vaccine candidate shows promising results Results from a phase 3 clinical trial of Pfizer's Lyme disease vaccine candidate found it was more than 70 percent effective at preventing the illness. © Associated Press Participants in...
Read full article at source